check_circleStudy Completed

Bronchiectasis

Bayer Identifier:

18449

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Treatment Patterns and Economic Burden of NCFB

Trial purpose

This observational database study used healthcare claims to understand costs and treatment pattern patients with non-cystic fibrosis bronchiectasis (NCFB) in the USA. Additionally, it looked at treatment patterns in this patient population to better understand how physicians respond in terms of treatment choices to an exacerbation.

Key Participants Requirements

Sex

All

Age

18 - N/A
  • - Adult NCFB patients with one claim for exacerbation during the enrollment period
  • - Patients with one primary or two secondary claims for COPD during the study period
    - Patients with any claims for cystic fibrosis or congential brochiectasis during the study period

Trial summary

Enrollment Goal
5847
Trial Dates
September 2015 - June 2016
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Ciprofloxacin DPI (BAYQ3939)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
United States

Primary Outcome

  • Cost and healthcare resource utilization
    Costs and healthcare resource utilization in patients with NCFB who have experienced at least one exacerbation due to NCFB both in patients with an exacerbation that lead to hospitalization and an exacerbation that did not lead to a hospitalization
    date_rangeTime Frame:
    Up to 4 years
  • Treatment pattern of NCFB patients
    Treatment patterns of patients with NCFB who have experienced at least one exacerbation due to NCFB both in patients with an exacerbation that lead to hospitalization and an exacerbation that did not lead to a hospitalization
    date_rangeTime Frame:
    Up to 4 years

Secondary Outcome

  • Comorbidities
    Common comorbidities and coexisting disease in patients with NCFB
    date_rangeTime Frame:
    Up to 4 years
  • Healthcare resource utilization after different numbers of exacerbations
    Differences in healthcare resource utilization in patients with 1, 2, or 3 average annual exacerbations
    date_rangeTime Frame:
    Up to 4 years

Trial design

Treatment Patterns and Healthcare Resource Utilization in Non Cystic Fibrosis Bronchiectasis (NCFB) Patients with Exacerbations
Trial Type
Observational
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to Bayer products.